These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 19515965)
1. Selective activation of the SK1 subtype of human small-conductance Ca2+-activated K+ channels by 4-(2-methoxyphenylcarbamoyloxymethyl)-piperidine-1-carboxylic acid tert-butyl ester (GW542573X) is dependent on serine 293 in the S5 segment. Hougaard C; Jensen ML; Dale TJ; Miller DD; Davies DJ; Eriksen BL; Strøbaek D; Trezise DJ; Christophersen P Mol Pharmacol; 2009 Sep; 76(3):569-78. PubMed ID: 19515965 [TBL] [Abstract][Full Text] [Related]
2. Evidence for a common pharmacological interaction site on K(Ca)2 channels providing both selective activation and selective inhibition of the human K(Ca)2.1 subtype. Hougaard C; Hammami S; Eriksen BL; Sørensen US; Jensen ML; Strøbæk D; Christophersen P Mol Pharmacol; 2012 Feb; 81(2):210-9. PubMed ID: 22046005 [TBL] [Abstract][Full Text] [Related]
3. Selective positive modulation of the SK3 and SK2 subtypes of small conductance Ca2+-activated K+ channels. Hougaard C; Eriksen BL; Jørgensen S; Johansen TH; Dyhring T; Madsen LS; Strøbaek D; Christophersen P Br J Pharmacol; 2007 Jul; 151(5):655-65. PubMed ID: 17486140 [TBL] [Abstract][Full Text] [Related]
4. Partial apamin sensitivity of human small conductance Ca2+-activated K+ channels stably expressed in Chinese hamster ovary cells. Dale TJ; Cryan JE; Chen MX; Trezise DJ Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):470-7. PubMed ID: 12382077 [TBL] [Abstract][Full Text] [Related]
5. Modulation of recombinant small-conductance Ca(2+)-activated K(+) channels by the muscle relaxant chlorzoxazone and structurally related compounds. Cao Y; Dreixler JC; Roizen JD; Roberts MT; Houamed KM J Pharmacol Exp Ther; 2001 Mar; 296(3):683-9. PubMed ID: 11181893 [TBL] [Abstract][Full Text] [Related]
6. Activation of SK channels inhibits epileptiform bursting in hippocampal CA3 neurons. Lappin SC; Dale TJ; Brown JT; Trezise DJ; Davies CH Brain Res; 2005 Dec; 1065(1-2):37-46. PubMed ID: 16336949 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory gating modulation of small conductance Ca2+-activated K+ channels by the synthetic compound (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphtylamine (NS8593) reduces afterhyperpolarizing current in hippocampal CA1 neurons. Strøbaek D; Hougaard C; Johansen TH; Sørensen US; Nielsen EØ; Nielsen KS; Taylor RD; Pedarzani P; Christophersen P Mol Pharmacol; 2006 Nov; 70(5):1771-82. PubMed ID: 16926279 [TBL] [Abstract][Full Text] [Related]
8. Negative gating modulation by (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) depends on residues in the inner pore vestibule: pharmacological evidence of deep-pore gating of K(Ca)2 channels. Jenkins DP; Strøbæk D; Hougaard C; Jensen ML; Hummel R; Sørensen US; Christophersen P; Wulff H Mol Pharmacol; 2011 Jun; 79(6):899-909. PubMed ID: 21363929 [TBL] [Abstract][Full Text] [Related]
9. Subtype-specific, bi-component inhibition of SK channels by low internal pH. Peitersen T; Hougaard C; Jespersen T; Jorgensen NK; Olesen SP; Grunnet M Biochem Biophys Res Commun; 2006 May; 343(3):943-9. PubMed ID: 16566895 [TBL] [Abstract][Full Text] [Related]
10. The small conductance Ca Rice CA; Stackman RW Neuropharmacology; 2024 Jul; 252():109960. PubMed ID: 38631563 [TBL] [Abstract][Full Text] [Related]
11. An apamin- and scyllatoxin-insensitive isoform of the human SK3 channel. Wittekindt OH; Visan V; Tomita H; Imtiaz F; Gargus JJ; Lehmann-Horn F; Grissmer S; Morris-Rosendahl DJ Mol Pharmacol; 2004 Mar; 65(3):788-801. PubMed ID: 14978258 [TBL] [Abstract][Full Text] [Related]
12. In vivo characterisation of the small-conductance KCa (SK) channel activator 1-ethyl-2-benzimidazolinone (1-EBIO) as a potential anticonvulsant. Anderson NJ; Slough S; Watson WP Eur J Pharmacol; 2006 Sep; 546(1-3):48-53. PubMed ID: 16925994 [TBL] [Abstract][Full Text] [Related]
13. A positive modulator of K Ca 2 and K Ca 3 channels, 4,5-dichloro-1,3-diethyl-1,3-dihydro-benzoimidazol-2-one (NS4591), inhibits bladder afferent firing in vitro and bladder overactivity in vivo. Hougaard C; Fraser MO; Chien C; Bookout A; Katofiasc M; Jensen BS; Rode F; Bitsch-Nørhave J; Teuber L; Thor KB; Strøbaek D; Burgard EC; Rønn LC J Pharmacol Exp Ther; 2009 Jan; 328(1):28-39. PubMed ID: 18820135 [TBL] [Abstract][Full Text] [Related]